These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model. Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279 [TBL] [Abstract][Full Text] [Related]
3. A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo. Ewe A; Przybylski S; Burkhardt J; Janke A; Appelhans D; Aigner A J Control Release; 2016 May; 230():13-25. PubMed ID: 27061141 [TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
5. Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery. Ewe A; Schaper A; Barnert S; Schubert R; Temme A; Bakowsky U; Aigner A Acta Biomater; 2014 Jun; 10(6):2663-73. PubMed ID: 24590163 [TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274 [TBL] [Abstract][Full Text] [Related]
7. Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivo. Zhang QY; Ho PY; Tu MJ; Jilek JL; Chen QX; Zeng S; Yu AM Int J Pharm; 2018 Aug; 547(1-2):537-544. PubMed ID: 29894758 [TBL] [Abstract][Full Text] [Related]
8. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588 [TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo. Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504 [TBL] [Abstract][Full Text] [Related]
10. Cationic Lipid-Coated Polyplexes (Lipopolyplexes) for DNA and Small RNA Delivery. Ewe A; Aigner A Methods Mol Biol; 2016; 1445():187-200. PubMed ID: 27436320 [TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes. Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615 [TBL] [Abstract][Full Text] [Related]
12. Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery. Schäfer J; Höbel S; Bakowsky U; Aigner A Biomaterials; 2010 Sep; 31(26):6892-900. PubMed ID: 20561681 [TBL] [Abstract][Full Text] [Related]
13. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice. Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980 [TBL] [Abstract][Full Text] [Related]
14. Composite liposome-PEI/nucleic acid lipopolyplexes for safe and efficient gene delivery and gene knockdown. Pinnapireddy SR; Duse L; Strehlow B; Schäfer J; Bakowsky U Colloids Surf B Biointerfaces; 2017 Oct; 158():93-101. PubMed ID: 28683347 [TBL] [Abstract][Full Text] [Related]
15. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264 [TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603 [TBL] [Abstract][Full Text] [Related]
17. Tumor tissue slice cultures as a platform for analyzing tissue-penetration and biological activities of nanoparticles. Merz L; Höbel S; Kallendrusch S; Ewe A; Bechmann I; Franke H; Merz F; Aigner A Eur J Pharm Biopharm; 2017 Mar; 112():45-50. PubMed ID: 27864052 [TBL] [Abstract][Full Text] [Related]
18. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery. Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of gambogenic acid and VEGF-siRNA with anionic liposome and polyethylenimine complexes to HepG2 cells. Yu Q; Zhang B; Zhou Y; Ge Q; Chang J; Chen Y; Zhang K; Peng D; Chen W J Liposome Res; 2019 Dec; 29(4):322-331. PubMed ID: 29745740 [No Abstract] [Full Text] [Related]
20. Sustained delivery of siRNA poly- and lipopolyplexes from porous macromer-crosslinked gelatin gels. Schwabe K; Ewe A; Kohn C; Loth T; Aigner A; Hacker MC; Schulz-Siegmund M Int J Pharm; 2017 Jun; 526(1-2):178-187. PubMed ID: 28456652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]